Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 48

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 48
---
 to purchase, purchase or cause to be purchased any of its outstanding securities; |

| (F) | not adopt a shareholder rights plan that provides rights to the Shareholders to purchase any securities of the 
 Company as a result of the Arrangement or the Contemplated Transactions;                                       |

| (G) | except for amendments to any existing Incentive Securities to facilitate the treatment of outstanding Incentive                                                                                                                                      
 Securities in accordance with the Discontinuance and the Plan of Arrangement, not enter into, adopt, establish, amend, modify or terminate any Employee Plan (or any arrangement that would be an Employee Plan if in effect as of the date hereof), 
 other than in connection with the Discontinuance;                                                                                                                                                                                                    |

| (H) | except for amendments to any existing Incentive Securities to facilitate the treatment of outstanding Incentive                                                                                                                                      
 Securities in accordance with the Discontinuance and the Plan of Arrangement, not increase or decrease any salary, incentives, benefits or other compensation, and not accelerate vesting of any benefits, of any officer, employee, director of the 
 Company or its Subsidiary under any Employee Plan, in each case, other than as contemplated by this Agreement or the Plan of Arrangement;                                                                                                            |

| (I) | not acquire or dispose of any securities, except in connection with the Discontinuance; |

| (J) | not reorganize, amalgamate, combine or merge the Company or the Subsidiary with any other person; |

| (K) | not create any Subsidiary; |

| (L) | not acquire or commit to acquire any assets or group of related assets (through one or more related or 
 unrelated acquisitions);                                                                               |

| (M) | not incur, or commit to, capital expenditures; |

| (N) | except (1) in connection with the Discontinuance, (2) for any (x) obsolete, damaged or destroyed                                                                                                                                               
 asset, (y) return of leased assets at the end of the lease term, or (z) transfer of assets between the Company and the Subsidiary, (3) as required pursuant to the terms of any Material Contract in effect on the date of this Agreement,     
 or (4) in connection with any Permitted Disposition, not sell, lease, option, encumber or otherwise dispose of, or commit to sell, lease, option, encumber or otherwise dispose of, any assets or group